Arizona State Retirement System - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 195 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
Arizona State Retirement System ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$231,479
-10.4%
5,724
+3.0%
0.00%0.0%
Q4 2022$258,419
-6.7%
5,555
+3.9%
0.00%
-33.3%
Q3 2022$277,000
+10.8%
5,347
+1.2%
0.00%
+50.0%
Q2 2022$250,000
-29.0%
5,285
+6.9%
0.00%
-33.3%
Q1 2022$352,000
-3.8%
4,945
+1.0%
0.00%0.0%
Q4 2021$366,000
+30.2%
4,897
-1.1%
0.00%
+50.0%
Q3 2021$281,000
+29.5%
4,951
+0.3%
0.00%0.0%
Q2 2021$217,000
-11.4%
4,935
-0.7%
0.00%0.0%
Q1 2021$245,000
+17.8%
4,968
+0.6%
0.00%0.0%
Q4 2020$208,000
-11.5%
4,937
-3.8%
0.00%0.0%
Q3 2020$235,000
-64.3%
5,131
-51.8%
0.00%
-75.0%
Q4 2019$658,000
-41.5%
10,655
-43.1%
0.01%
-42.9%
Q3 2019$1,125,000
-46.0%
18,724
-24.2%
0.01%
-41.7%
Q2 2019$2,085,000
-10.1%
24,715
+1.7%
0.02%
-14.3%
Q1 2019$2,320,000
+35.2%
24,293
+0.3%
0.03%
+27.3%
Q4 2018$1,716,000
-11.8%
24,229
+6.4%
0.02%
+22.2%
Q3 2018$1,946,000
-20.3%
22,769
+8.0%
0.02%
-28.0%
Q2 2018$2,443,000
+33.1%
21,082
-7.1%
0.02%
+31.6%
Q1 2018$1,836,000
+30.4%
22,697
-5.4%
0.02%
+35.7%
Q4 2017$1,408,000
+306.9%
23,997
+224.3%
0.01%
+250.0%
Q3 2017$346,000
+33.6%
7,400
+2.8%
0.00%0.0%
Q2 2017$259,000
+16.7%
7,2000.0%0.00%
+33.3%
Q1 2017$222,000
-7.9%
7,2000.0%0.00%
-25.0%
Q4 2016$241,000
+14.2%
7,200
+12.5%
0.00%
+33.3%
Q4 2015$211,000
-7.5%
6,400
+1.6%
0.00%0.0%
Q3 2015$228,0006,3000.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,599,109$63,277,0008.68%
SENZAR ASSET MANAGEMENT, LLC 566,903$22,432,0006.58%
Sarissa Capital Management LP 105,000$4,155,0001.60%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 136,637$5,407,0001.41%
RA Capital Management 250,000$9,893,0001.17%
BENNETT LAWRENCE MANAGEMENT L L C/NY 110,515$4,373,0000.99%
Ghost Tree Capital, LLC 35,000$1,385,0000.75%
WALL STREET ASSOCIATES 159,100$6,296,0000.65%
BAILARD, INC. 91,500$3,621,0000.56%
EAM Investors, LLC 62,768$2,484,0000.50%
View complete list of ENANTA PHARMACEUTICALS INC shareholders